For decades, Americans have unknowingly subsidized the global pharmaceutical industry—paying up to 10 times more for the exact same drugs sold in Europe, Canada, and Australia. While foreign governments negotiate rock-bottom prices, U.S. lawmakers—captured by Big Pharma’s lobbying machine—let American patients foot the bill. Donald Trump’s "Most Favored Nation" executive order challenged the cartel’s pricing scheme, threatening the transnational scam. This article exposes how media complicity, institutional corruption, and political cowardice turned the U.S. into the cash cow of global healthcare.
Big Pharma’s Global Cartel
For decades, Americans have unknowingly subsidized the global pharmaceutical industry—paying up to 10 times more for the exact same drugs sold in Europe, Canada, and Australia. While foreign governments negotiate rock-bottom prices, U.S. lawmakers—captured by Big Pharma’s lobbying machine—let American patients foot the bill. Donald Trump’s "Most Favored Nation" executive order challenged the cartel’s pricing scheme, threatening the transnational scam. This article exposes how media complicity, institutional corruption, and political cowardice turned the U.S. into the cash cow of global healthcare.